EFMC: Trends in Medicinal Chemistry and Chemical Biology

Author:

Auberson Yves P.1ORCID,Arimondo Paola B.2,Duca Maria3,Essig Sebastian4,Grether Uwe5,Rufer Arne C.5,Sbardella Gianluca6,Schopfer Ulrich7,Torrens Antoni8,van der Stelt Mario9,Vauzeilles Boris10,Vázquez Olalla11,Zhang Andrew X.12

Affiliation:

1. Global Discovery Chemistry Novartis Institutes for BioMedical Research Novartis Campus - WSJ-88.10 4056 Basel Switzerland

2. Department Epigenetic Chemical Biology Institut Pasteur, Université de Paris CNRS UMR3523 Chem4Life 28 rue du Dr Roux 75015 Paris France

3. Université Côte d'Azur Institut de Chimie de Nice (ICN), UMR7272 CNRS Parc Valrose 06100 Nice France

4. Bayer AG, Research & Development, Pharmaceuticals Drug Discovery Sciences, Life Science Technologies Aprather Weg 18a, Gebäude 460, Raum 345 42113 Wuppertal Germany

5. F. Hoffmann-La Roche Ltd. Pharma Research and Early Development, pRED Roche Innovation Center Basel Grenzacherstrasse 124 4070 Basel Switzerland

6. Epigenetic Med Chem Lab Department of Pharmacy, University of Salerno via Giovanni Paolo II 132 84084 Fisciano (SA) Italy

7. Chemical Biology and Therapeutics Novartis Institutes for BioMedical Research Novartis Campus – WSJ-182.Z4.249.14 4056 Basel Switzerland

8. ABAC Therapeutics S.L. Joan XXIII, 10 08950 Esplugues de Llobregat Barcelona Spain

9. University of Leiden Institute of Chemistry/Chemical Biology Gorlaeus Building, room DE3.19 Einsteinweg 55 2333 CC Leiden The Netherlands

10. Chemical Biology Department Université Paris-Saclay, CNRS Institut de Chimie des Substances Naturelles UPR 2301 91198 Gif-sur-Yvette France

11. Philipps-Universität Marburg Department of Chemistry & Center for Synthetic Microbiology (SYNMIKRO) D-35032 Marburg Germany

12. Discovery Sciences, R&D, AstraZeneca Waltham MA 02451 USA

Abstract

AbstractGround‐breaking research in disease biology and continuous efforts in method development have uncovered a range of potential new drug targets. Increasingly, the drug discovery process is informed by technologies involving chemical probes as tools. Applications for chemical probes comprise target identification and assessment, as well as the qualification of small molecules as chemical starting points and drug candidates. Progress in probe chemistry has opened the way to novel assay formats and pharmaceutical compound classes. The European Federation of Medicinal Chemistry and Chemical Biology (EFMC) has launched the Chemical Biology Initiative to advance science in the field of medicinal chemistry and chemical biology, while representing all members of this extended scientific community. This review provides an overview of the many important developments in the field of chemical biology that have happened at the lively interface of academic and industrial research.

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Reference275 articles.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3